Matches in Nanopublications for { ?s ?p "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP513047.RAoLKkiYU8mrs8KZilA6GpIH6XGsnINxrk12ex4c6uzrY130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513047.RAoLKkiYU8mrs8KZilA6GpIH6XGsnINxrk12ex4c6uzrY130_provenance.
- NP881346.RAptNpJWWJhMBEWDwbO8BRcCAn0WAqB_VEkw_DRMnp3wo130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881346.RAptNpJWWJhMBEWDwbO8BRcCAn0WAqB_VEkw_DRMnp3wo130_provenance.
- NP239022.RAVoFXjQpWRDwvrc1jbYe5A1eLABBzwFrVQlzZpjlW6S0130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP239022.RAVoFXjQpWRDwvrc1jbYe5A1eLABBzwFrVQlzZpjlW6S0130_provenance.
- NP238890.RAgF3Bh5ulX343_YZf1MILiVFObKRfq-jEk1oWBIMTXY8130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238890.RAgF3Bh5ulX343_YZf1MILiVFObKRfq-jEk1oWBIMTXY8130_provenance.
- NP238933.RAx7gTYTZdLWtImJlzyRBISlFMRNJMxtPe2EW98KhP450130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238933.RAx7gTYTZdLWtImJlzyRBISlFMRNJMxtPe2EW98KhP450130_provenance.
- NP304318.RAFOcP0daKH0GXXu8FxD3IE77RqeaKCVdlv8a-f9rYRyU130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304318.RAFOcP0daKH0GXXu8FxD3IE77RqeaKCVdlv8a-f9rYRyU130_provenance.
- NP304321.RAw4zfreccuZ6lmUVRsWq9Q5U7FRqdRssHQEQdf3P46fM130_assertion description "[CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304321.RAw4zfreccuZ6lmUVRsWq9Q5U7FRqdRssHQEQdf3P46fM130_provenance.